These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 33156945)
1. Treatments of gliosarcoma of the brain: a systematic review and meta-analysis. Wang X; Jiang J; Liu M; You C Acta Neurol Belg; 2021 Dec; 121(6):1789-1797. PubMed ID: 33156945 [TBL] [Abstract][Full Text] [Related]
3. The clinical, radiological, and immunohistochemical characteristics and outcomes of primary intracranial gliosarcoma: a retrospective single-centre study. Zhang Y; Ma JP; Weng JC; Wang L; Wu Z; Li D; Zhang JT Neurosurg Rev; 2021 Apr; 44(2):1003-1015. PubMed ID: 32189095 [TBL] [Abstract][Full Text] [Related]
4. Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series. Castelli J; Feuvret L; Haoming QC; Biau J; Jouglar E; Berger A; Truc G; Gutierrez FL; Morandi X; Le Reste PJ; Thillays F; Loussouarn D; Nouhaud E; Crehange G; Antoni D; Vauleon E; de Crevoisier R; Noel G J Neurooncol; 2016 Aug; 129(1):85-92. PubMed ID: 27169763 [TBL] [Abstract][Full Text] [Related]
5. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840 [TBL] [Abstract][Full Text] [Related]
6. Treatment and survival of patients harboring histological variants of glioblastoma. Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627 [TBL] [Abstract][Full Text] [Related]
7. Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis. Hanna C; Lawrie TA; Rogozińska E; Kernohan A; Jefferies S; Bulbeck H; Ali UM; Robinson T; Grant R Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013261. PubMed ID: 32202316 [TBL] [Abstract][Full Text] [Related]
8. Secondary gliosarcoma: the clinicopathological features and the development of a patient-derived xenograft model of gliosarcoma. Kiang KM; Chan AA; Leung GK BMC Cancer; 2021 Mar; 21(1):265. PubMed ID: 33706745 [TBL] [Abstract][Full Text] [Related]
9. Primary gliosarcoma--clinical experience from a regional cancer centre in north India. Biswas A; Kumar N; Kumar P; Vasishta RK; Gupta K; Sharma SC; Patel F; Mathuriya SN Br J Neurosurg; 2011 Dec; 25(6):723-9. PubMed ID: 21591852 [TBL] [Abstract][Full Text] [Related]
10. Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma. Butowski N; Chang SM; Lamborn KR; Polley MY; Pieper R; Costello JF; Vandenberg S; Parvataneni R; Nicole A; Sneed PK; Clarke J; Hsieh E; Costa BM; Reis RM; Hristova-Kazmierski M; Nicol SJ; Thornton DE; Prados MD Neuro Oncol; 2011 Dec; 13(12):1331-8. PubMed ID: 21896554 [TBL] [Abstract][Full Text] [Related]
11. Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years. Ohno M; Miyakita Y; Takahashi M; Igaki H; Matsushita Y; Ichimura K; Narita Y Radiat Oncol; 2019 Nov; 14(1):200. PubMed ID: 31718669 [TBL] [Abstract][Full Text] [Related]
13. Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy. Damodaran O; van Heerden J; Nowak AK; Bynevelt M; McDonald K; Marsh J; Lee G J Clin Neurosci; 2014 Mar; 21(3):478-81. PubMed ID: 24332268 [TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of temozolomide versus radiotherapy in elderly glioblastoma patients. Yin AA; Cai S; Dong Y; Zhang LH; Liu BL; Cheng JX; Zhang X J Neurooncol; 2014 Jan; 116(2):315-24. PubMed ID: 24178440 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors of Gliosarcoma in the Real World: A Retrospective Cohort Study. Yu Z; Zhou Z; Xu M; Song K; Shen J; Zhu W; Wei L; Xu H Comput Math Methods Med; 2023; 2023():1553408. PubMed ID: 36756387 [TBL] [Abstract][Full Text] [Related]
16. Temozolomide for high grade glioma. Hart MG; Garside R; Rogers G; Stein K; Grant R Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007415. PubMed ID: 23633341 [TBL] [Abstract][Full Text] [Related]
17. Surgery, radiotherapy and temozolomide in treating high-grade gliomas. Parlato C; Barbarisi M; Moraci M; Moraci A Front Biosci; 2006 May; 11():1280-3. PubMed ID: 16368514 [TBL] [Abstract][Full Text] [Related]
18. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review. Ashby LS; Smith KA; Stea B World J Surg Oncol; 2016 Aug; 14(1):225. PubMed ID: 27557526 [TBL] [Abstract][Full Text] [Related]
19. Gliosarcoma: a clinical and radiological analysis of 48 cases. Yi X; Cao H; Tang H; Gong G; Hu Z; Liao W; Sun L; Chen BT; Li X Eur Radiol; 2019 Jan; 29(1):429-438. PubMed ID: 29948068 [TBL] [Abstract][Full Text] [Related]
20. Comparative epidemiology of gliosarcoma and glioblastoma and the impact of Race on overall survival: A systematic literature review. Gerges C; Elder T; Penuela M; Rossetti N; Maynard M; Jeong S; Wright CH; Wright J; Zhou X; Burant C; Sajatovic M; Hodges T Clin Neurol Neurosurg; 2020 Aug; 195():106054. PubMed ID: 32650210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]